Skip to main content
OpenTrials

Clinical trial condition

Secondary Myelofibrosis

Explore clinical trials studying Secondary Myelofibrosis. Study availability and eligibility vary by location and protocol.

30 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Secondary Myelofibrosis trial results

Completed

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

NCT00445744

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +39 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases

NCT00438958

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +61 more
Locations
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Institute of Medical and Veterinary Science Adelaide, South Australia, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
  • Vancouver Hospital and Health Science Center Vancouver, British Columbia, Canada
View all 16 locations
View Trial Details
Active, Not Recruiting

Decitabine in Treating Patients With Myelofibrosis

NCT00095784

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
  • NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View all 14 locations
View Trial Details

Related conditions